Bloomberg Originals
@business·5.1M subscribers·49.5K videos
Inside the $160B Pfizer-Allergan Record Deal
Posted
November 23, 2015
Views
5,027
Likes
16
Comments
3
Engagement
0.38%
November 23, 2015
5,027
16
3
0.38%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:56Now PlayingNov. 23 -- Pfizer Inc. and Allergan Plc said they would combine operations in a stock transaction worth about $160 billion, creating a drugmaking behemoth with products from Viagra to Botox and a low-cost tax base. Jefferies Chief Market Strategist David Zervos and Bloomberg's Cynthia Koons speak on "Bloomberg ‹GO›."
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
